Nutraceuticals in Veterinary Medicine
暫譯: 獸醫藥用營養品

這本獨特的著作匯集了有關獸醫營養補充劑（通常稱為膳食補充劑）的最新知識，從成分到最終產品，皆在單一來源中整合。全書包含超過六十章，分為七個部分，彙整了動物健康與疾病相關的所有營養補充劑研究方面，其中包括許多新穎主題：常見的營養補充劑成分（第一部分）、益生元、益生菌、共生菌、酶和抗菌替代品（第二部分）、營養補充劑在預防和治療各種疾病（如關節炎、牙周炎、糖尿病、認知功能障礙、乳腺炎、傷口、免疫疾病和癌症）的應用（第三部分）、在特定動物物種中利用營養補充劑（第四部分）、營養補充劑和功能性食品的安全性與毒性評估（第五部分）、營養補充劑研究和產品開發的最新趨勢（第六部分），以及營養補充劑的法規方面（第七部分）。獸醫學中營養補充劑和功能性食品的未來似乎光明，因為新型的營養補充劑將會出現，並且舊有成分的新用途將被發現。

本書的國際貢獻者涵蓋了獸醫學、藥理學、藥用植物學、毒理學、化學、藥物化學、生物化學、生理學、營養學、藥物開發、法規框架以及營養補充劑產業等多個專業領域。這是一本資訊豐富且精心呈現的書籍，為學術界、獸醫、政府及監管機構提供了有關動物營養、輔助獸醫學、營養補充劑產品開發和研究的科學見解。

Dr. Ramesh C. Gupta serves as Professor and Head of the Toxicology Department at the Murray State University Breathitt Veterinary Center. He earned his DVM, MVSc, and PhD in India, and carried out his postdoctoral training at Michigan State University and Vanderbilt University, US. His research has addressed experimental brain research in relation to pesticide toxicity and neurological diseases; he has further been heavily engaged in veterinary nutraceuticals research. Dr. Gupta has held worldwide presentations and served on the panels of NIH, CDC, NIOSH, and NAS. He has published >400 publications, including 7 major books. In 2006, he received the Murray State University Distinguished Researcher Award; and in 2014, the Outstanding Research Award. He is a Diplomate of the American Board of Toxicology, and Fellow of the American College of Toxicology, American College of Nutrition, and Academy of Toxicological Sciences. Currently, he holds active membership in more than a dozen academic societies.

Dr. Ajay Srivastava is Chief Scientific Officer at Vets Plus Inc., and serves as an adjunct Faculty member at University of Wisconsin-Stout, Menomonie, US. He is specialized in preclinical and clinical product development and nutraceutical research. After receiving his BS in Biological Sciences, Dr. Srivastava earned his DVM from the School of Veterinary Medicine at GB Pant University of Agriculture and Technology, India, before pursuing his MS in Pharmacology. He completed his PhD in Neuropharmacology from All India Institute of Medical Sciences, New Delhi. After his post-doctoral training in preclinical drug development in neurological disorders, Dr. Srivastava became Senior Research Scientist of the Anticonvulsant Drug Development Program at the University of Utah, where he developed a novel animal model of pharmacoresistant epilepsy to screen potential antiepileptic drugs. He is one of the pioneer researchers who discovered the role of nutraceuticals resveratrol and melatonin in epilepsy. Dr. Srivastava has chaired various scientific sessions in AVMA and WVC meetings and has published several research articles in peer reviewed journals. He has contributed chapters in textbooks on epilepsy, toxicology and nutraceuticals.

Mr. Rajiv Lall is the Founder and CEO of Vets Plus, Inc., an international leader in the animal health industry. He graduated with two masters degrees, the first in Botany from his native country of India, and the second in Pharmacognosy/Medicinal Chemistry from the University of Minnesota. His research focused on identifying, analyzing, and extracting natural ingredients from plants and plant tissue cultures that provide natural health and medicinal properties, as well as on enzymes in relation to cancer cells through animal cell cultures. Mr. Lall started his career in the human health food industry with an emphasis on probiotics. His relentless drive continues to champion animal health through scientific research and the development of nutritional products and pharmaceuticals, and through these efforts he has obtained various patents and developed several hundred products. His company, Vets Plus, Inc. is a research and science-based product development company with a strong quality and manufacturing platform to support partners in Europe and around the world. Recent awards include the Pet Age Icon Award (2015), NASC Visibility Award (2015), and Menomonie Area Chamber of Commerce Business of the Year Award (2015). Vets Plus Inc. was also nominated for Wisconsin Manufacturer of the Year in 2015. In support of the animal health industry, Mr. Lall is now Founder and CEO of Noble Pharma, LLC, a pharmaceutical company in Menomonie, Wisconsin. Mr. Lall and his wife Swati are involved in philanthropic efforts and through that they have developed the Raj and Swati Lall Microbiology Laboratory at the University of Wisconsin-Stout in support of future scientists and business leaders and the community in Menomonie, Wisconsin.

拉梅什·C·古普塔博士擔任穆雷州立大學布雷希特獸醫中心毒理學系的教授及系主任。他在印度獲得了獸醫學士（DVM）、獸醫科學碩士（MVSc）和博士學位（PhD），並在美國密西根州立大學和范德堡大學進行了博士後訓練。他的研究涉及與農藥毒性和神經疾病相關的實驗性腦研究；此外，他還積極參與獸醫營養保健品的研究。古普塔博士曾在全球各地進行演講，並擔任美國國立衛生研究院（NIH）、疾病控制與預防中心（CDC）、國家職業安全衛生研究所（NIOSH）和美國國家科學院（NAS）的專家小組成員。他已發表超過400篇論文，包括7本主要著作。2006年，他獲得穆雷州立大學傑出研究者獎；2014年，獲得傑出研究獎。他是美國毒理學委員會的專家會員，並且是美國毒理學學院、美國營養學院和毒理科學學院的院士。目前，他在十多個學術社團中擔任活躍會員。

阿賈伊·斯里瓦斯塔瓦博士是Vets Plus Inc.的首席科學官，並擔任美國威斯康辛州斯陶特大學的兼任教員。他專注於臨床前和臨床產品開發及營養保健品研究。在獲得生物科學學士學位後，斯里瓦斯塔瓦博士在印度GB Pant農業與技術大學的獸醫學院獲得獸醫學士（DVM），隨後攻讀藥理學碩士學位。他在新德里的全印度醫學科學院完成了神經藥理學博士學位。完成神經疾病臨床前藥物開發的博士後訓練後，斯里瓦斯塔瓦博士成為猶他大學抗癲癇藥物開發計劃的高級研究科學家，並開發了一種新型的藥物抗性癲癇動物模型，以篩選潛在的抗癲癇藥物。他是發現營養保健品白藜蘆醇和褪黑激素在癲癇中作用的先驅研究者之一。斯里瓦斯塔瓦博士曾在美國獸醫醫學會（AVMA）和西部獸醫會（WVC）會議上主持多個科學會議，並在同行評審期刊上發表了多篇研究文章。他在癲癇、毒理學和營養保健品的教科書中貢獻了章節。

拉吉夫·拉爾先生是Vets Plus, Inc.的創始人兼首席執行官，該公司是動物健康行業的國際領導者。他擁有兩個碩士學位，第一個是來自他故鄉印度的植物學，第二個是來自明尼蘇達大學的藥用植物學/藥物化學。他的研究專注於從植物及植物組織培養中識別、分析和提取具有自然健康和藥用特性的天然成分，以及通過動物細胞培養研究與癌細胞相關的酶。拉爾先生在以益生菌為重點的人類健康食品行業開始了他的職業生涯。他不懈的努力繼續通過科學研究和營養產品及藥物的開發來推動動物健康，並通過這些努力獲得了多項專利並開發了數百種產品。他的公司Vets Plus, Inc.是一家以研究和科學為基礎的產品開發公司，擁有強大的質量和製造平台，以支持歐洲及全球的合作夥伴。最近的獎項包括寵物年齡圖標獎（2015年）、NASC可見性獎（2015年）和梅諾莫尼商會年度商業獎（2015年）。Vets Plus Inc.在2015年也被提名為威斯康辛州年度製造商。為了支持動物健康行業，拉爾先生目前是Noble Pharma, LLC的創始人兼首席執行官，這是一家位於威斯康辛州梅諾莫尼的製藥公司。拉爾先生和他的妻子斯瓦蒂參與慈善事業，並通過這些努力在威斯康辛州斯陶特大學建立了拉吉和斯瓦蒂·拉爾微生物學實驗室，以支持未來的科學家和商業領袖以及梅諾莫尼社區。